Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 683 | $4.9984 | 0 (Direct) | View |
| 2023-08-11 Disposition | 2023-08-11 4:10 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 683 | $6.6439 | 0 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-22 8:14 pm | 2024-06-21 2033-06-20 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 4:33 pm | N/A 2033-06-07 | Sana Biotechnology Inc. | SANA | Cole Douglas G. Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 6:01 pm | N/A 2033-06-01 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 16,865 | $0 | 39,213 (Direct) | View |
| 2023-05-19 Option Award | 2023-05-22 4:20 pm | N/A 2033-05-18 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 8,888 | $0 | 8,888 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 9:00 pm | 2023-06-21 2032-06-20 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-08 6:35 pm | N/A 2032-06-05 | Sana Biotechnology Inc. | SANA | Cole Douglas G. Director | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 8:09 pm | N/A 2032-06-02 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 23,945 | $0 | 40,307 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 5:00 pm | N/A 2032-05-25 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 8,888 | $0 | 8,888 (Direct) | View |
| 2021-07-13 Option Award | 2021-07-14 4:52 pm | 2022-07-13 2031-07-12 | Foghorn Therapeutics Inc. | FHTX | Cole Douglas G. Director | 12,530 | $0 | 12,530 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 07:15 am | N/A 2031-06-23 | Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director | 8,888 | $9.97 | 8,888 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 6:31 pm | N/A 2031-06-02 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 8,296 | $0 | 11,549 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 8:51 pm | N/A N/A | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 3,253 | $0 | 3,253 (Direct) | View |
| 2021-02-03 Option Award(A) | 2021-02-18 6:58 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | Cole Douglas G. Director | 23,591 | $0 | 23,591 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 5:16 pm | N/A 2031-02-02 | Sana Biotechnology Inc. | SANA | Cole Douglas G. Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:58 pm | N/A 2030-06-02 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 18,436 | $0 | 18,436 (Direct) | View |
| 2019-05-30 Option Award | 2019-05-31 6:28 pm | N/A 2029-05-29 | Denali Therapeutics Inc. | DNLI | Cole Douglas G. Director | 27,245 | $0 | 27,245 (Direct) | View |